Literature DB >> 16236077

Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in primary care.

S E Gillard1, A Y Finlay.   

Abstract

The current management of psoriasis and its associated resource use in the United Kingdom (UK) was investigated in this retrospective analysis of 789,300 primary care patient records. Most patients with psoriasis (94%) were managed on topical psoriasis agents only, 4% were prescribed systemic psoriasis agents and 2% had no recorded psoriasis treatment at all during the 12-month study period. Co-medications to treat physical or psychological comorbidities were required by 22% of patients. Referral rates into secondary care were low, 5% of patients prescribed systemic psoriasis agents and 0.7% of patients prescribed topical psoriasis agents had secondary care appointments documented in their medical records. This study demonstrates that most patients with psoriasis in UK primary care are managed on topical agents even though there are surrogate markers, such as resource use and co-medication prescriptions, which indicate that their psoriasis is not optimally controlled.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236077     DOI: 10.1111/j.1368-5031.2005.00680.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  7 in total

1.  Topical delivery of a naproxen-dithranol co-drug: in vitro skin penetration, permeation, and staining.

Authors:  Wing Man Lau; Alex W White; Charles M Heard
Journal:  Pharm Res       Date:  2010-09-25       Impact factor: 4.200

2.  Incidence of psoriasis in children: a population-based study.

Authors:  Megha M Tollefson; Cynthia S Crowson; Marian T McEvoy; Hilal Maradit Kremers
Journal:  J Am Acad Dermatol       Date:  2009-12-05       Impact factor: 11.527

3.  Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.

Authors:  Yves Poulin; Norman Wasel; Daphne Chan; Geula Bernstein; Robin Andrew; Elisa Fraquelli; Kim Papp
Journal:  Can Fam Physician       Date:  2012-07       Impact factor: 3.275

4.  Definition of treatment goals for moderate to severe psoriasis: a European consensus.

Authors:  U Mrowietz; K Kragballe; K Reich; P Spuls; C E M Griffiths; A Nast; J Franke; C Antoniou; P Arenberger; F Balieva; M Bylaite; O Correia; E Daudén; P Gisondi; L Iversen; L Kemény; M Lahfa; T Nijsten; T Rantanen; A Reich; T Rosenbach; S Segaert; C Smith; T Talme; B Volc-Platzer; N Yawalkar
Journal:  Arch Dermatol Res       Date:  2010-09-21       Impact factor: 3.017

5.  Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study.

Authors:  Javaria Mona Khalid; Gary Globe; Kathleen M Fox; Dina Chau; Andrew Maguire; Chio-Fang Chiou
Journal:  BMC Dermatol       Date:  2013-08-19

6.  Epidemiology and Clinical Features of Adult Patients with Psoriasis in Malaysia: 10-Year Review from the Malaysian Psoriasis Registry (2007-2016).

Authors:  Azura Mohd Affandi; Iman Khan; Nooraishah Ngah Saaya
Journal:  Dermatol Res Pract       Date:  2018-04-23

7.  Design, synthesis and in vitro degradation of a novel co-drug for the treatment of psoriasis.

Authors:  Wing Man Lau; Charles M Heard; Alex W White
Journal:  Pharmaceutics       Date:  2013-04-17       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.